{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:34:11Z","timestamp":1795138451035,"version":"4.10.3"},"reference-count":139,"publisher":"Aging and Disease","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2015]]},"DOI":"10.14336\/ad.2014.0305","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T17:10:48Z","timestamp":1427476248000},"page":"109","source":"Crossref","is-referenced-by-count":507,"title":["Metabolic Syndrome, Aging and Involvement of Oxidative Stress"],"prefix":"10.14336","volume":"6","author":[{"given":"Francesca","family":"Bonomini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Fabrizio","family":"Rodella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rezzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2014.0305-1","doi-asserted-by":"crossref","unstructured":"Humphreys MH (2011). The brain splits obesity and hypertension. Nat Med, 17:782\u20133.","DOI":"10.1038\/nm0711-782"},{"key":"key-10.14336\/AD.2014.0305-2","doi-asserted-by":"crossref","unstructured":"Kahn SE,Hull RL,Utzschneider KM (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444: 840\u20136.","DOI":"10.1038\/nature05482"},{"key":"key-10.14336\/AD.2014.0305-3","doi-asserted-by":"crossref","unstructured":"Giovannucci E,Michaud D (2007). The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology, 132:2208\u201325.","DOI":"10.1053\/j.gastro.2007.03.050"},{"key":"key-10.14336\/AD.2014.0305-4","doi-asserted-by":"crossref","unstructured":"Parekh S,Anania FA (2007). Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology, 132:2191\u2013207.","DOI":"10.1053\/j.gastro.2007.03.055"},{"key":"key-10.14336\/AD.2014.0305-5","doi-asserted-by":"crossref","unstructured":"Bamba V,Rader DJ (2007). Obesity and atherogenic dyslipidemia. Gastroenterology, 132:2181\u201390.","DOI":"10.1053\/j.gastro.2007.03.056"},{"key":"key-10.14336\/AD.2014.0305-6","doi-asserted-by":"crossref","unstructured":"Van Gaal LF,Mertens IL,De Block CE (2006). Mechanisms linking obesity with cardiovascular disease. Nature, 444:875\u201380.","DOI":"10.1038\/nature05487"},{"key":"key-10.14336\/AD.2014.0305-7","doi-asserted-by":"crossref","unstructured":"Semenkovich CF (2006). Insulin resistance and atherosclerosis. J Clin Invest, 116:1813\u201322.","DOI":"10.1172\/JCI29024"},{"key":"key-10.14336\/AD.2014.0305-8","doi-asserted-by":"crossref","unstructured":"Friedman JM (2009). Obesity: Causes and control of excess body fat. Nature, 459:340\u20132.","DOI":"10.1038\/459340a"},{"key":"key-10.14336\/AD.2014.0305-9","doi-asserted-by":"crossref","unstructured":"Ogden CL,Yanovski SZ,Carroll MD,Flegal KM (2007). The epidemiology of obesity. Gastroenterology, 132:2087\u2013102.","DOI":"10.1053\/j.gastro.2007.03.052"},{"key":"key-10.14336\/AD.2014.0305-10","doi-asserted-by":"crossref","unstructured":"Yoon KH,Lee JH,Kim JW,Cho JH,Choi YH,Ko SHet al. (2006). Epidemic obesity and type 2 diabetes in Asia. Lancet, 368:1681\u20138.","DOI":"10.1016\/S0140-6736(06)69703-1"},{"key":"key-10.14336\/AD.2014.0305-11","doi-asserted-by":"crossref","unstructured":"Abelson P,Kennedy D (2004). The obesity epidemic. Science, 304:1413.","DOI":"10.1126\/science.304.5676.1413"},{"key":"key-10.14336\/AD.2014.0305-12","doi-asserted-by":"crossref","unstructured":"Zimmet P,Alberti KG,Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature, 414:782\u20137.","DOI":"10.1038\/414782a"},{"key":"key-10.14336\/AD.2014.0305-13","doi-asserted-by":"crossref","unstructured":"Despres JP,Lemieux I (2006). Abdominal obesity and metabolic syndrome. Nature, 444:881\u20137.","DOI":"10.1038\/nature05488"},{"key":"key-10.14336\/AD.2014.0305-14","doi-asserted-by":"crossref","unstructured":"Eckel RH,Grundy SM,Zimmet PZ (2005). The metabolic syndrome. Lancet, 365:1415\u201328.","DOI":"10.1016\/S0140-6736(05)66378-7"},{"key":"key-10.14336\/AD.2014.0305-15","doi-asserted-by":"crossref","unstructured":"Guarente L (2006). Sirtuins as potential targets for metabolic syndrome. Nature, 444:868\u201374.","DOI":"10.1038\/nature05486"},{"key":"key-10.14336\/AD.2014.0305-16","unstructured":"Duvnjak L,Duvnjak M (2009). The metabolic syndrome - an ongoing story. J. Physiol. Pharmacol, 60(Suppl 7):19\u201324."},{"key":"key-10.14336\/AD.2014.0305-17","doi-asserted-by":"crossref","unstructured":"Gaddam KK,Ventura HO,Lavie CJ (2011). Metabolic syndrome and heart failure-the risk, paradox, and treatment. Curr Hypertens Rep, 13:142\u20138.","DOI":"10.1007\/s11906-011-0179-x"},{"key":"key-10.14336\/AD.2014.0305-18","doi-asserted-by":"crossref","unstructured":"Rodriguez A,Muller DC,Metter EJ,Maggio M,Harman SM,Blackman MRet al. (2007). Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab, 92:3568\u201372.","DOI":"10.1210\/jc.2006-2764"},{"key":"key-10.14336\/AD.2014.0305-19","doi-asserted-by":"crossref","unstructured":"Moulana M,Lima R,Reckelhoff JF (2011). Metabolic syndrome, androgens, and hypertension. Curr Hypertens Rep, 13:158\u201362.","DOI":"10.1007\/s11906-011-0184-0"},{"key":"key-10.14336\/AD.2014.0305-20","doi-asserted-by":"crossref","unstructured":"Cai D,Liu T (2012). Inflammatory cause of metabolic syndrome via brain stress and NF-\u03baB. Aging (Albany NY), 4(2):98\u2013115.","DOI":"10.18632\/aging.100431"},{"key":"key-10.14336\/AD.2014.0305-21","doi-asserted-by":"crossref","unstructured":"Wilson PW,D\u2019Agostino RB,Parise H,Sullivan L,Meigs JB (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 112:3066\u201372.","DOI":"10.1161\/CIRCULATIONAHA.105.539528"},{"key":"key-10.14336\/AD.2014.0305-22","doi-asserted-by":"crossref","unstructured":"Katzmaryk PT,Leon AS,Wilmore JH,Skinner JS,Rao DC,Rankinen T, et al. (2003). Targeting the metabolic syndrome with exercise: evidence from the heritage family study. Medial Sci Sports Exerc, 35(10):1703\u20139.","DOI":"10.1249\/01.MSS.0000089337.73244.9B"},{"key":"key-10.14336\/AD.2014.0305-23","unstructured":"Fauci AS (2008). Harrison\u2019s principles of internal medicine. McGraw-Hill Medical. ISBN 0-07-147692-X."},{"key":"key-10.14336\/AD.2014.0305-24","doi-asserted-by":"crossref","unstructured":"Grundy SM,Cleeman JI,Daniels SR,Donato KA,Eckel RH,Franklin BA,Gordon DJ,Krauss RM,Savage PJ,Smith SCJr,Spertus JA,Costa F; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112: 2735\u20132752.","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"key-10.14336\/AD.2014.0305-25","doi-asserted-by":"crossref","unstructured":"Borch-Johnsen K,Wareham N (2010). The rise and fall of the metabolic syndrome. Diabetologia, 53: 597\u2013599.","DOI":"10.1007\/s00125-010-1659-2"},{"key":"key-10.14336\/AD.2014.0305-26","doi-asserted-by":"crossref","unstructured":"Guize L,Thomas F,Pannier B,Bean K,Jego B,Benetos A (2007). All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care, 30: 2381\u20132387.","DOI":"10.2337\/dc07-0186"},{"key":"key-10.14336\/AD.2014.0305-27","doi-asserted-by":"crossref","unstructured":"Zambon S,Zanoni S,Romanato G,Corti MC,Noale M,Sartori Let al. (2009). Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) study. Diabetes Care, 32:153\u2013159.","DOI":"10.2337\/dc08-1256"},{"key":"key-10.14336\/AD.2014.0305-28","doi-asserted-by":"crossref","unstructured":"Nunn AV,Bell JD,Guy GW (2009) Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe?. Nutr Metab (Lond.), 6: 16.","DOI":"10.1186\/1743-7075-6-16"},{"key":"key-10.14336\/AD.2014.0305-29","doi-asserted-by":"crossref","unstructured":"Haffner S,Taegtmeyer H (2003) Epidemic obesity and the metabolic syndrome. Circulation, 108: 1541\u20131545.","DOI":"10.1161\/01.CIR.0000088845.17586.EC"},{"key":"key-10.14336\/AD.2014.0305-30","doi-asserted-by":"crossref","unstructured":"Harman D (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11:298\u2013300.","DOI":"10.1093\/geronj\/11.3.298"},{"key":"key-10.14336\/AD.2014.0305-31","doi-asserted-by":"crossref","unstructured":"Harman D (1972). The biologic clock: the mitochondria?. J. Am. Geriatr. Soc., 20: 145\u2013147.","DOI":"10.1111\/j.1532-5415.1972.tb00787.x"},{"key":"key-10.14336\/AD.2014.0305-32","doi-asserted-by":"crossref","unstructured":"Miquel J,Economos AC,Fleming J,Johnson Jr JE (1980). Mitochondrial role in cell aging. Exp Gerontol, 15:575\u2013591.","DOI":"10.1016\/0531-5565(80)90010-8"},{"key":"key-10.14336\/AD.2014.0305-33","doi-asserted-by":"crossref","unstructured":"Pak JW,Herbst A,Bua E,Gokey N,McKenzie D,Aiken JM (2003). Mitochondrial DNA mutations as a fundamental mechanism in physiological declines associated with aging. Aging Cell, 2:1\u20137.","DOI":"10.1046\/j.1474-9728.2003.00034.x"},{"key":"key-10.14336\/AD.2014.0305-34","doi-asserted-by":"crossref","unstructured":"Wei YH (1992). Mitochondrial DNA alterations as ageing-associated molecular events. Mutat Res, 275:145\u2013155.","DOI":"10.1016\/0921-8734(92)90019-L"},{"key":"key-10.14336\/AD.2014.0305-35","doi-asserted-by":"crossref","unstructured":"Richter C (1995). Oxidative damage to mitochondrial DNA and its relationship to ageing. Int. J. Biochem. Cell Biol, 27:647\u2013653.","DOI":"10.1016\/1357-2725(95)00025-K"},{"key":"key-10.14336\/AD.2014.0305-36","doi-asserted-by":"crossref","unstructured":"Linnane AW,Marzuki S,Ozawa T,Tanaka M (1989). Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet, 1: 642\u2013645.","DOI":"10.1016\/S0140-6736(89)92145-4"},{"key":"key-10.14336\/AD.2014.0305-37","doi-asserted-by":"crossref","unstructured":"Judge S,Leeuwenburgh C (2007). Cardiac mitochondrial bioenergetics, oxidative stress, and aging. Am J Physiol Cell Physiol, 292:C1983\u2013C1992.","DOI":"10.1152\/ajpcell.00285.2006"},{"key":"key-10.14336\/AD.2014.0305-38","doi-asserted-by":"crossref","unstructured":"Sohal RS,Weindruch R (1996). Oxidative stress, caloric restriction, and aging. Science: 5: 59\u201363.","DOI":"10.1126\/science.273.5271.59"},{"key":"key-10.14336\/AD.2014.0305-39","doi-asserted-by":"crossref","unstructured":"Beckman KB,Ames BN (1998). The free radical theory of aging matures. Physiol Rev, 78: 547\u2013581.","DOI":"10.1152\/physrev.1998.78.2.547"},{"key":"key-10.14336\/AD.2014.0305-40","doi-asserted-by":"crossref","unstructured":"Cortopassi GA,Shibata D,Soong NW,Arnheim NA (1992). A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA, 89:7370\u20137374.","DOI":"10.1073\/pnas.89.16.7370"},{"key":"key-10.14336\/AD.2014.0305-41","doi-asserted-by":"crossref","unstructured":"Hayakawa M,Hattori K,Sugiyama S,Ozawa T (1992). Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun, 189(2):979\u201385.","DOI":"10.1016\/0006-291X(92)92300-M"},{"key":"key-10.14336\/AD.2014.0305-42","doi-asserted-by":"crossref","unstructured":"Paradies G,Ruggiero FM,Quagliariello E (1992).Age-dependent changes in the activity of anion carriers and in the lipid composition in rat heart mitochondria. Ann NY Acad Sci, 26:160\u2013164.","DOI":"10.1111\/j.1749-6632.1992.tb27448.x"},{"key":"key-10.14336\/AD.2014.0305-43","doi-asserted-by":"crossref","unstructured":"Paradies G,uggiero FM,Quagliariello E (1992). Age-dependent changes in the activity of anion carriers and in the lipid composition in rat heart mitochondria. Ann NY Acad Sci, 26:160\u2013164.","DOI":"10.1111\/j.1749-6632.1992.tb27448.x"},{"key":"key-10.14336\/AD.2014.0305-44","doi-asserted-by":"crossref","unstructured":"Shigenaga MK,Hagen TMAmes BN (1994). Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA, 91:10771\u201310778.","DOI":"10.1073\/pnas.91.23.10771"},{"key":"key-10.14336\/AD.2014.0305-45","doi-asserted-by":"crossref","unstructured":"Lesnefsky EJ,Moghaddas S,Tandler B,Kerner J,Hoppel CL (2001). Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33:1065\u20131089.","DOI":"10.1006\/jmcc.2001.1378"},{"key":"key-10.14336\/AD.2014.0305-46","doi-asserted-by":"crossref","unstructured":"Paradies G,Petrosillo G,Paradies V,Ruggiero FM (2010). Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging. Free Radic Biol Med, 48(10):1286\u201395.","DOI":"10.1016\/j.freeradbiomed.2010.02.020"},{"key":"key-10.14336\/AD.2014.0305-47","doi-asserted-by":"crossref","unstructured":"Wellen KE,Hotamisligil GS (2005). Inflammation, stress, and diabetes. J Clin Invest, 115:1111\u20139.","DOI":"10.1172\/JCI25102"},{"key":"key-10.14336\/AD.2014.0305-48","doi-asserted-by":"crossref","unstructured":"Stocker R,Keaney Jr JF (2004). Role of oxidative modifications in atherosclerosis. Physiol Rev, 84:1381\u2013478.","DOI":"10.1152\/physrev.00047.2003"},{"key":"key-10.14336\/AD.2014.0305-49","doi-asserted-by":"crossref","unstructured":"Furukawa S,Fujita T,Shimabukuro M,Iwaki M,Yamada Y,Nakajima Yet al. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 114:1752\u201361.","DOI":"10.1172\/JCI21625"},{"key":"key-10.14336\/AD.2014.0305-50","doi-asserted-by":"crossref","unstructured":"Grattagliano I,Vendemiale G,Boscia F,Micelli-Ferrari T,Cardia L,Altomare E (1998). Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med, 25:369\u201372.","DOI":"10.1016\/S0891-5849(98)00059-8"},{"key":"key-10.14336\/AD.2014.0305-51","doi-asserted-by":"crossref","unstructured":"Grattagliano I,Vendemiale G,Caraceni P,Domenicali M,Nardo B,Cavallari Aet al. (2000). Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. J Nutr, 130(9):2131\u20136.","DOI":"10.1093\/jn\/130.9.2131"},{"key":"key-10.14336\/AD.2014.0305-52","doi-asserted-by":"crossref","unstructured":"Portincasa P.,Grattagliano I.,Palmieri V.O.,Palasciano G (2005). Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem, 38:203\u2013217.","DOI":"10.1016\/j.clinbiochem.2004.10.014"},{"key":"key-10.14336\/AD.2014.0305-53","doi-asserted-by":"crossref","unstructured":"Sies H (1997). Oxidative stress: oxidants and antioxidants. Exp Physiol, 82:291\u2013295.","DOI":"10.1113\/expphysiol.1997.sp004024"},{"key":"key-10.14336\/AD.2014.0305-54","doi-asserted-by":"crossref","unstructured":"Vendemiale G.,Grattagliano I.,Altomare E (1999). An update on the role of free radicals and antioxidant defense in human disease. Int J Clin Lab Res, 29: 49\u201355.","DOI":"10.1007\/s005990050063"},{"key":"key-10.14336\/AD.2014.0305-55","doi-asserted-by":"crossref","unstructured":"Knopp RH,Paramsothy P (2006). Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome. Am J Clin Nutr, 83(1):1\u20132.","DOI":"10.1093\/ajcn\/83.1.1"},{"key":"key-10.14336\/AD.2014.0305-56","doi-asserted-by":"crossref","unstructured":"S\u00e1ez GT,Tormos C,Giner V,Chaves J,Lozano JV,Iradi A, et al. (2004). Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens, 17:809\u201316.","DOI":"10.1016\/j.amjhyper.2004.05.022"},{"key":"key-10.14336\/AD.2014.0305-57","doi-asserted-by":"crossref","unstructured":"Palmieri VO,Grattagliano I,Portincasa P,Palasciano G (2006). Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr, 136:3022\u20136.","DOI":"10.1093\/jn\/136.12.3022"},{"key":"key-10.14336\/AD.2014.0305-58","doi-asserted-by":"crossref","unstructured":"Couillard C,Ruel G,Archer WR,Pomerleau S,Bergeron J,Couture Pet al. (2005). Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab, 90:6454\u20139.","DOI":"10.1210\/jc.2004-2438"},{"key":"key-10.14336\/AD.2014.0305-59","doi-asserted-by":"crossref","unstructured":"Keaney JFJr,Larson MG,Vasan RS,Wilson PW,Lipinska I,Corey Det al. (2003). Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol, 23:434\u20139.","DOI":"10.1161\/01.ATV.0000058402.34138.11"},{"key":"key-10.14336\/AD.2014.0305-60","doi-asserted-by":"crossref","unstructured":"Pinzani M,Marra F,Carloni V (1998). Signal transduction in hepatic stellate cells. Liver, 18:2\u201313.","DOI":"10.1111\/j.1600-0676.1998.tb00120.x"},{"key":"key-10.14336\/AD.2014.0305-61","doi-asserted-by":"crossref","unstructured":"Suthanthiran M.,Anderson M.E.,Sharma V.K.,Meister A (1990). Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci U S A, 87:3343\u20133347.","DOI":"10.1073\/pnas.87.9.3343"},{"key":"key-10.14336\/AD.2014.0305-62","doi-asserted-by":"crossref","unstructured":"Sahaf B,Heydari K,Herzenberg LA,Herzenberg LA (2005). The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects. Arch Biochem Biophys, 434:26\u201332.","DOI":"10.1016\/j.abb.2004.11.015"},{"key":"key-10.14336\/AD.2014.0305-63","doi-asserted-by":"crossref","unstructured":"Vendemiale G,Guerrieri F,Grattagliano I,Didonna D,Muolo L,Altomare E (1995). Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration. Hepatology, 21:1450\u20131454.","DOI":"10.1002\/hep.1840210532"},{"key":"key-10.14336\/AD.2014.0305-64","doi-asserted-by":"crossref","unstructured":"Grattagliano I,Palmieri VO,Portincasa P,Moschetta A,Palasciano G (2008). Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem, 19(8):491\u2013504.","DOI":"10.1016\/j.jnutbio.2007.06.011"},{"key":"key-10.14336\/AD.2014.0305-65","doi-asserted-by":"crossref","unstructured":"Czech MP,Lawrence JCJr,Lynn WS (1974). Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci SA, 71:4173\u20134177.","DOI":"10.1073\/pnas.71.10.4173"},{"key":"key-10.14336\/AD.2014.0305-66","doi-asserted-by":"crossref","unstructured":"Higaki Y,Mikami T,Fujii N,Hirshman MF,Koyama K,Seino Tet al. (2008). Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol-3-kinase dependent pathway. Am J Physiol Endocrinol Metab, 294:E889\u2013E897.","DOI":"10.1152\/ajpendo.00150.2007"},{"key":"key-10.14336\/AD.2014.0305-67","doi-asserted-by":"crossref","unstructured":"May JM,de Haen C (1979). The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem, 254:9017\u20139021.","DOI":"10.1016\/S0021-9258(19)86803-5"},{"key":"key-10.14336\/AD.2014.0305-68","doi-asserted-by":"crossref","unstructured":"Powell DJ,Hajduch E,Kular G,Hundal HS (2003). Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol, 23:7794\u20137808.","DOI":"10.1128\/MCB.23.21.7794-7808.2003"},{"key":"key-10.14336\/AD.2014.0305-69","doi-asserted-by":"crossref","unstructured":"Pessler D,Rudich A,Bashan N (2001). Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter. Diabetologia, 44:2156\u20132164.","DOI":"10.1007\/s001250100024"},{"key":"key-10.14336\/AD.2014.0305-70","doi-asserted-by":"crossref","unstructured":"Kamigaki M,Sakaue S,Tsujino I,Ohira H,Ikeda D,Itoh N,Ishimaru S,Ohtsuka Y,Nishimura M (2006). Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun, 339:624\u2013632.","DOI":"10.1016\/j.bbrc.2005.11.059"},{"key":"key-10.14336\/AD.2014.0305-71","doi-asserted-by":"crossref","unstructured":"Furukawa S,Fujita T,Shimabukuro M,Iwaki M,Yamada Y,Nakajima Yet al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 114:1752\u20131761.","DOI":"10.1172\/JCI21625"},{"key":"key-10.14336\/AD.2014.0305-72","doi-asserted-by":"crossref","unstructured":"Svegliati-Baroni G,Candelaresi C,Saccomanno S,Ferretti G,Bachetti T,Marzioni Met al. (2006). A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol, 169:846\u2013860.","DOI":"10.2353\/ajpath.2006.050953"},{"key":"key-10.14336\/AD.2014.0305-73","doi-asserted-by":"crossref","unstructured":"Schaffer SW,Jong CJ,Mozaffari M (2012). Role of oxidative stress in diabetes-mediated vasculardysfunction: Unifying hypothesis of diabetes revisited. Vascul Pharmacol, 57:139\u2013149.","DOI":"10.1016\/j.vph.2012.03.005"},{"key":"key-10.14336\/AD.2014.0305-74","doi-asserted-by":"crossref","unstructured":"Campia U,Tesauro M,Cardillo C (2012). Human obesity and endothelium-dependent responsiveness. Br J Pharmacol, 165:561\u2013573.","DOI":"10.1111\/j.1476-5381.2011.01661.x"},{"key":"key-10.14336\/AD.2014.0305-75","doi-asserted-by":"crossref","unstructured":"Tesauro M,Cardillo C (2011). Obesity, blood vessels and metabolic syndrome. Acta Physiol (Oxf), 203:279\u2013286.","DOI":"10.1111\/j.1748-1716.2011.02290.x"},{"key":"key-10.14336\/AD.2014.0305-76","doi-asserted-by":"crossref","unstructured":"Stadler K (2012). Oxidative stress in diabetes. Adv Exp Med Biol, 771: 272\u2013287.","DOI":"10.1007\/978-1-4614-5441-0_21"},{"key":"key-10.14336\/AD.2014.0305-77","doi-asserted-by":"crossref","unstructured":"Davi G,Ciabattoni G,Consoli A,Mezzetti A,Falco A,Santarone Set al (1999). In vivo formation of 8-iso-prostaglandin F2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation, 99:224\u2013229.","DOI":"10.1161\/01.CIR.99.2.224"},{"key":"key-10.14336\/AD.2014.0305-78","doi-asserted-by":"crossref","unstructured":"Davi G,Chiarelli F,Santilli F,Pomilio M,Vigneri S,Falco Aet al. (2003). Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation, 107:3199\u20133203.","DOI":"10.1161\/01.CIR.0000074205.17807.D0"},{"key":"key-10.14336\/AD.2014.0305-79","doi-asserted-by":"crossref","unstructured":"Monnier L,Mas E,Ginet C,Michel F,Villon L,Cristol JPet al. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295(14):1681\u20137.","DOI":"10.1001\/jama.295.14.1681"},{"key":"key-10.14336\/AD.2014.0305-80","doi-asserted-by":"crossref","unstructured":"Pitocco D,Zaccardi F,Di Stasio E,Romitelli F,Martini F,Scaglione GLet al. (2009). Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite\/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. Diabetes Res Clin Pract, 86(3):173\u20136.","DOI":"10.1016\/j.diabres.2009.09.019"},{"key":"key-10.14336\/AD.2014.0305-81","doi-asserted-by":"crossref","unstructured":"Pitocco D,Zaccardi F,Di Stasio E,Romitelli F,Santini SA,Zuppi Cet al. (2010). Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud, 7(1):15\u201325.","DOI":"10.1900\/RDS.2010.7.15"},{"key":"key-10.14336\/AD.2014.0305-82","doi-asserted-by":"crossref","unstructured":"Wellen KE,Hotamisligil GS (2003). Obesity-induced inflammatory changes in adipose tissue. J Clin Invest, 112:1785\u20138.","DOI":"10.1172\/JCI20514"},{"key":"key-10.14336\/AD.2014.0305-83","doi-asserted-by":"crossref","unstructured":"Lugogo NL,Bappanad D,Kraft M (2011). Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta, 1810:1120\u20136.","DOI":"10.1016\/j.bbagen.2011.09.004"},{"key":"key-10.14336\/AD.2014.0305-84","doi-asserted-by":"crossref","unstructured":"Keaney JFJr.,Larson MG,Vasan RS,Wilson P W,LIpinska I,Corey Det al. (2003). Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol, 23: 434\u2013439.","DOI":"10.1161\/01.ATV.0000058402.34138.11"},{"key":"key-10.14336\/AD.2014.0305-85","doi-asserted-by":"crossref","unstructured":"Vincent HK,Bourguignon CM,Taylor AG (2010). Relationship of the dietary phytochemical index to weight gain, oxidative stress and inflammation in overweight young adults. J Hum Nutr Diet, 23:20\u20139.","DOI":"10.1111\/j.1365-277X.2009.00987.x"},{"key":"key-10.14336\/AD.2014.0305-86","doi-asserted-by":"crossref","unstructured":"Couillard C,Ruel G,Archer WR,Pomerleau S,Bergeron J,Couture Pet al. (2005). Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab, 90:6454\u20139.","DOI":"10.1210\/jc.2004-2438"},{"key":"key-10.14336\/AD.2014.0305-87","doi-asserted-by":"crossref","unstructured":"Fujita K,Nishizawa H,Funahashi T,Shimomura I,Shimabukuro M (2006). Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J, 70(11):1437\u201342.","DOI":"10.1253\/circj.70.1437"},{"key":"key-10.14336\/AD.2014.0305-88","doi-asserted-by":"crossref","unstructured":"Steffes MW,Gross MD,Lee DH,Schreiner PJ,Jacobs DRJr (2006). Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity, 14(2):319\u201326.","DOI":"10.1038\/oby.2006.41"},{"key":"key-10.14336\/AD.2014.0305-89","doi-asserted-by":"crossref","unstructured":"Wu B,Fukuo K,Suzuki K,Yoshino G,Kazumi T (2009). Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women. Endocr J, 56(6):773\u201382.","DOI":"10.1507\/endocrj.K08E-332"},{"key":"key-10.14336\/AD.2014.0305-90","doi-asserted-by":"crossref","unstructured":"Shaheen M,Echeverry D,Oblad MG,Montoya MI,Teklehaimanot S,Akhtar AJ (2007). Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract, 75(3):320\u20136.","DOI":"10.1016\/j.diabres.2006.07.008"},{"key":"key-10.14336\/AD.2014.0305-91","doi-asserted-by":"crossref","unstructured":"Roberts CK,Sindhu KK (2009). Oxidative stress and metabolic syndrome. Life Sci, 84(21\u201322):705\u201312.","DOI":"10.1016\/j.lfs.2009.02.026"},{"key":"key-10.14336\/AD.2014.0305-92","doi-asserted-by":"crossref","unstructured":"Nayak DU,Karmen C,Frishman WH,Vakili BA (2001). Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease. Heart Dis, 3:28\u201345.","DOI":"10.1097\/00132580-200101000-00006"},{"key":"key-10.14336\/AD.2014.0305-93","doi-asserted-by":"crossref","unstructured":"Kizhakekuttu TJ,Widlansky ME (2010). Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther, 28:e20\u2013e32.","DOI":"10.1111\/j.1755-5922.2010.00137.x"},{"key":"key-10.14336\/AD.2014.0305-94","doi-asserted-by":"crossref","unstructured":"Kitiyakara C,Wilcox C (1998). Antioxidants for hypertension. Curr Opin Nephrol Hypertens, 7:531\u2013538.","DOI":"10.1097\/00041552-199809000-00008"},{"key":"key-10.14336\/AD.2014.0305-95","doi-asserted-by":"crossref","unstructured":"Russo C,Olivieri O,Girelli D,Faccini G,Zenari ML,Lombardi S,Corrocher R (1998). Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens, 16:1267\u20131271.","DOI":"10.1097\/00004872-199816090-00007"},{"key":"key-10.14336\/AD.2014.0305-96","unstructured":"Tse WY,Maxwell SR,Thomason H,Blann A,Thorpe GH,Waite Met al. (1994). Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens.;8:843\u2013849."},{"key":"key-10.14336\/AD.2014.0305-97","doi-asserted-by":"crossref","unstructured":"Mansego ML,Solar Gde M,Alonso MP,Mart\u00ednez F,S\u00e1ez GT,Escudero JCet al. (2011) Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens, 29:492\u2013500.","DOI":"10.1097\/HJH.0b013e328341f1b2"},{"key":"key-10.14336\/AD.2014.0305-98","doi-asserted-by":"crossref","unstructured":"Galley HF,Thornton J,Howdle PD,Walker BE,Webster NR (1997). Combination oral antioxidant supplementation reduces blood pressure. Clin Sci, 92:361\u2013365.","DOI":"10.1042\/cs0920361"},{"key":"key-10.14336\/AD.2014.0305-99","doi-asserted-by":"crossref","unstructured":"Broadhurst CL (1997). Balanced intakes of natural triglycerides for optimum nutrition: an evolutionary and phytochemical perspective. Med Hypotheses, 49:247\u2013261.","DOI":"10.1016\/S0306-9877(97)90210-3"},{"key":"key-10.14336\/AD.2014.0305-100","doi-asserted-by":"crossref","unstructured":"Houston MC (2007). Treatment of hypertension with nutraceuticals. vitamins, antioxidants and minerals. Expert Rev Cardiovasc Ther, 5:681\u2013691.","DOI":"10.1586\/14779072.5.4.681"},{"key":"key-10.14336\/AD.2014.0305-101","doi-asserted-by":"crossref","unstructured":"Dhalla NS,Temsah RM,Netticadam T (2000). The role of oxidative stress in cardiovascular diseases. J Hypertens, 18:655\u2013673.","DOI":"10.1097\/00004872-200018060-00002"},{"key":"key-10.14336\/AD.2014.0305-102","doi-asserted-by":"crossref","unstructured":"Touyz RM (2004). Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension, 44(3):248\u201352.","DOI":"10.1161\/01.HYP.0000138070.47616.9d"},{"key":"key-10.14336\/AD.2014.0305-103","doi-asserted-by":"crossref","unstructured":"Nishihara M,Hirooka Y,Matsukawa R,Kishi T,Sunagawa K (2012). Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J. Hypertension, 30: 97\u2013106.","DOI":"10.1097\/HJH.0b013e32834e1df4"},{"key":"key-10.14336\/AD.2014.0305-104","doi-asserted-by":"crossref","unstructured":"Konno S,Hirooka Y,Kishi T,Sunagawa K (2012). Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats. J Hypertens, 30:1992\u20131999.","DOI":"10.1097\/HJH.0b013e328357fa98"},{"key":"key-10.14336\/AD.2014.0305-105","doi-asserted-by":"crossref","unstructured":"Houston M (2013). Nutrition and nutraceutical supplements for the treatment of hypertension: part I. J Clin Hypertens, 15(10):752\u20137.","DOI":"10.1111\/jch.12188"},{"key":"key-10.14336\/AD.2014.0305-106","doi-asserted-by":"crossref","unstructured":"Brownlee M (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813\u2013820.","DOI":"10.1038\/414813a"},{"key":"key-10.14336\/AD.2014.0305-107","doi-asserted-by":"crossref","unstructured":"Avignon A,Radauceanu A,Monnier L (1997). Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care, 20:1822\u20131826.","DOI":"10.2337\/diacare.20.12.1822"},{"key":"key-10.14336\/AD.2014.0305-108","doi-asserted-by":"crossref","unstructured":"El-Kebbi IM,Ziemer DC,Cook CB,Gallina DL,Barnes CS,Philipps LS (2004). Utility of casual postprandial glucose levels in type 2 diabetes management. Diabetes Care, 27:335\u2013339.","DOI":"10.2337\/diacare.27.2.335"},{"key":"key-10.14336\/AD.2014.0305-109","doi-asserted-by":"crossref","unstructured":"Rohlfing CL,Wiedmeyer HS,Little RR,England JD,Tennill A,Goldstein DE (2002). Defining the relationship between plasma glucose and HbA1c. Diabetes Care, 25:275\u2013278.","DOI":"10.2337\/diacare.25.2.275"},{"key":"key-10.14336\/AD.2014.0305-110","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2007). Standards of medical care in diabetes-2007. Diabetes Care, 30(S1):S4\u2013S41.","DOI":"10.2337\/dc07-S004"},{"key":"key-10.14336\/AD.2014.0305-111","doi-asserted-by":"crossref","unstructured":"Sacks DB,Bruns DE,Goldstein DE,Mac Laren NK,Mac Donald JM,Parrott M (2002). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (position statement). Diabetes Care, 25:750\u2013786.","DOI":"10.2337\/diacare.25.4.750"},{"key":"key-10.14336\/AD.2014.0305-112","doi-asserted-by":"crossref","unstructured":"Gorus F,Mathieu C,Gerlo E (2006). How should HbA1 measurements be reported? Diabetologia, 49:7\u201310.","DOI":"10.1007\/s00125-005-0073-7"},{"key":"key-10.14336\/AD.2014.0305-113","doi-asserted-by":"crossref","unstructured":"Morrow JD,Hill KE,Burk RF,Nammour TM,Badr KF,Roberts LJ (1991). A series of prostaglandin F2-like compounds are produced in vivo in humans by non-cyclooxygenase free radical-catalyzed mechanism. Proc Natl Acad Sci USA, 87:9383\u20139387.","DOI":"10.1073\/pnas.87.23.9383"},{"key":"key-10.14336\/AD.2014.0305-114","doi-asserted-by":"crossref","unstructured":"Roberts LJ,Morrow JD (2000). Measurement of F (2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Bio Med, 28:505\u2013513.","DOI":"10.1016\/S0891-5849(99)00264-6"},{"key":"key-10.14336\/AD.2014.0305-115","doi-asserted-by":"crossref","unstructured":"Basu S (1998). Metabolism of 8-iso-prostaglandin F2\u03b1. FEBS Lett, 428:32\u201336.","DOI":"10.1016\/S0014-5793(98)00481-5"},{"key":"key-10.14336\/AD.2014.0305-116","doi-asserted-by":"crossref","unstructured":"Davi G,Falco A,Patrono C (2005). Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal, 7:256\u2013258.","DOI":"10.1089\/ars.2005.7.256"},{"key":"key-10.14336\/AD.2014.0305-117","doi-asserted-by":"crossref","unstructured":"Monnier L,Mas E,Ginet C,Michel F,Villon L,Cristol J-Pet al. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295:1681\u20131687.","DOI":"10.1001\/jama.295.14.1681"},{"key":"key-10.14336\/AD.2014.0305-118","doi-asserted-by":"crossref","unstructured":"Colette C,Monnier L (2007). Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. Horm Metab Res, 39(9):683\u20136.","DOI":"10.1055\/s-2007-985157"},{"key":"key-10.14336\/AD.2014.0305-119","doi-asserted-by":"crossref","unstructured":"Ruotolo G,Howard BV (2002). Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep, 4:494\u2013500.","DOI":"10.1007\/s11886-002-0113-6"},{"key":"key-10.14336\/AD.2014.0305-120","doi-asserted-by":"crossref","unstructured":"Jeppesen J,Hollenbeck CB,Zhou MY,Coulston AM,Jones C,Chen YDet al (1995). Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol, 15:320\u20134.","DOI":"10.1161\/01.ATV.15.3.320"},{"key":"key-10.14336\/AD.2014.0305-121","doi-asserted-by":"crossref","unstructured":"de Oliveira J,Hort MA,Moreira EL,Glaser V,Ribeiro-do-Valle RM,Prediger RDet al. (2011). Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience, 197:99\u2013106.","DOI":"10.1016\/j.neuroscience.2011.09.009"},{"key":"key-10.14336\/AD.2014.0305-122","doi-asserted-by":"crossref","unstructured":"Marques de Mattos A,Marino LV,Ovidio PP,Jord\u00e3o AA,Almeida CC,Chiarello PG (2012). Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial, 16:68\u201374.","DOI":"10.1111\/j.1744-9987.2011.01009.x"},{"key":"key-10.14336\/AD.2014.0305-123","doi-asserted-by":"crossref","unstructured":"Zelzer S,Fuchs N,Almer G,Raggam RB,Pr\u00fcller F,Truschnig-Wilders Met al. (2011). High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers. Clin Chim Acta, 412:1345\u20139.","DOI":"10.1016\/j.cca.2011.03.031"},{"key":"key-10.14336\/AD.2014.0305-124","doi-asserted-by":"crossref","unstructured":"Andreadou I,Farmakis D,Prokovas E,Sigala F,Zoga A,Spyridaki Ket al. (2012). Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. Cardiovasc Res, 94:501\u20139.","DOI":"10.1093\/cvr\/cvs121"},{"key":"key-10.14336\/AD.2014.0305-125","unstructured":"Ansari JA,Bhandari U,Pillai KK,Haque SE (2012). Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study. Indian J Exp Biol, 50(3):216\u201322."},{"key":"key-10.14336\/AD.2014.0305-126","doi-asserted-by":"crossref","unstructured":"Hutcheson R,Rocic P (2012). The metabolic syndrome, oxidative stress,environment, and cardiovascular disease: the great exploration. Exp Diabetes Res, 2012: 271028.","DOI":"10.1155\/2012\/271028"},{"key":"key-10.14336\/AD.2014.0305-127","unstructured":"Guarner V,Carb\u00f3 R,Rubio ME, Ba\u00f1os de MacCarthy G (2005). Aging of the cardiovascular system. In:Benhagen EF, editor. Hypertension: New research. Nova Biomedical Books; USA, 47\u201368."},{"key":"key-10.14336\/AD.2014.0305-128","doi-asserted-by":"crossref","unstructured":"Kenyon CJ (2010). The genetics of aging. Nature, 464:504\u2013512.","DOI":"10.1038\/nature08980"},{"key":"key-10.14336\/AD.2014.0305-129","doi-asserted-by":"crossref","unstructured":"Rincon M,Rudin E,Barzilai N (2005). The insulin\/IGF-1 signaling in mammals and its relevance to human longevity. Exp Gerontol, 40:873\u2013877.","DOI":"10.1016\/j.exger.2005.06.014"},{"key":"key-10.14336\/AD.2014.0305-130","doi-asserted-by":"crossref","unstructured":"Rozing MP,Westendorp RGJ,Fr\u00f6lich M,de Craen AJM,Beekman M,Heijmans BTet al. (2009). Human insulin\/IGF-1 and familial longevity at middle age. Aging, 1:714\u2013722.","DOI":"10.18632\/aging.100071"},{"key":"key-10.14336\/AD.2014.0305-131","unstructured":"Guarner V,Carb\u00f3 R,Rubio ME,Ba\u00f1os de MacCarthy G (2005). Aging of the cardiovascular system. In:Benhagen EF, editor. Hypertension: New Research. USA: Nova Biomedical Books Publishers, 47\u201368."},{"key":"key-10.14336\/AD.2014.0305-132","unstructured":"Ba\u00f1os G,El Hafidi M,P\u00e9rez-Torres I,Guarner V (2009). Insulin resistance and the metabolic syndrome. In:Yao EB, editor. Insulin Resistance: New Research. USA: Nova Biomedical Books Publishers, 49\u201397."},{"key":"key-10.14336\/AD.2014.0305-133","doi-asserted-by":"crossref","unstructured":"Guarner V,Rubio-Ruiz ME,Perez-Torres I,Ba\u00f1os de McCarthy G (2011). Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease. Exp Gerontol, 46:517\u2013523.","DOI":"10.1016\/j.exger.2011.02.007"},{"key":"key-10.14336\/AD.2014.0305-134","doi-asserted-by":"crossref","unstructured":"Fadini GP,Ceolotto G,Pagnin E,de Kreutzenberg S,Avogaro A (2011). At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell, 10:10\u201317.","DOI":"10.1111\/j.1474-9726.2010.00642.x"},{"key":"key-10.14336\/AD.2014.0305-135","doi-asserted-by":"crossref","unstructured":"Ren J,Pulakat L,Whaley-Connell A,Sowers JR (2010). Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. Mol Med, 88:993\u20131001.","DOI":"10.1007\/s00109-010-0663-9"},{"key":"key-10.14336\/AD.2014.0305-136","unstructured":"Veronica G,Esther RR (2012). Aging, metabolic syndrome and the heart. Aging Dis, 3:269\u201379."},{"key":"key-10.14336\/AD.2014.0305-137","doi-asserted-by":"crossref","unstructured":"Passos JF,Saretzki G,Ahmed S,Nelson G,Richter T,Peters Het al. (2007). Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol, 5:e110.","DOI":"10.1371\/journal.pbio.0050110"},{"key":"key-10.14336\/AD.2014.0305-138","doi-asserted-by":"crossref","unstructured":"Bonomini F,Rodella LF,Moghadasian M,Lonati C,Coleman R,Rezzani R (2011). Role of apolipoprotein E in renal damage protection. Histochem Cell Biol, 135(6):571\u20139.","DOI":"10.1007\/s00418-011-0815-1"},{"key":"key-10.14336\/AD.2014.0305-139","doi-asserted-by":"crossref","unstructured":"Kong CM,Lee XW,Wang X (2013). Telomere shortening in human diseases. FEBS J, 280:3180\u201393.","DOI":"10.1111\/febs.12326"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/2152-5250-2015-2-109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:20:09Z","timestamp":1627759209000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2014.0305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2014.0305","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}